9. Apr, 2022
Věčné téma: myocarditidy po mRNA vakcinách
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19
vaccination or SARS-CoV-2 infection
Martina Patone1, Xue W. Mei 1, Lahiru Handunnetthi 2, Sharon Dixon1, Francesco Zaccardi3,
Manu Shankar-Hari 4,5,6, Peter Watkinson 7,8, Kamlesh Khunti3, Anthony Harnden1,
Carol A. C. Coupland 1,9, Keith M. Channon10, Nicholas L. Mills 4,11, Aziz Sheikh 4 and
Julia Hippisley-Cox
Summary: In summary, this population-based study quantifies for the
first time the risk of several rare cardiac adverse events associated
with three COVID-19 vaccines as well as SARS-CoV-2 infection.
Vaccination for SARS-CoV-2 in adults was associated with a small
increase in the risk of myocarditis within a week of receiving the
first dose of both adenovirus and mRNA vaccines, and after the
second dose of both mRNA vaccines. By contrast, SARS-CoV-2
infection was associated with a substantial increase in the risk of
hospitalization or death from myocarditis, pericarditis and cardiac
arrhythmia.
Celý text najdete na:
Nature Medicine | VOL 28 | Febru 410 ary 2022 | 410–422 | www.nature.com/naturemedicine